Sensorion Announces Webconference, in French, for its Retail Shareholders on April 7, 2025
Monday, 31 March 2025 () MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced it will host a webconference for its retail shareholders on April 7, 2025, following its Full-Year 2024 release. The webconference will be held in French. Sensorion’s Chief Executive Officer, Nawal Ouzren, and management team, will host a w
Monday, 31 March 2025 ()
